Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AML

Bone Marrow Transplantation

Volumn 19, Issue 9, 1997, Pages 947-949

  Nachbaur, D ^a   Duba, H C ^a   Feichtinger, H ^a   Kropshofer, G ^a   Nussbaumer, W ^a   Schwaighofer, H ^a   Niederwieser, D ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Allogeneic bone marrow transplantation; Donor buffy coat transfusion; Graft versus leukemia (GVL) effect; Granulocytic sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENT; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASIA; ARTICLE; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; GRAFT VERSUS HOST REACTION; GRANULOCYTIC SARCOMA; HUMAN; MALE; PRIORITY JOURNAL; RELAPSE;

EID: 0030929139     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700766     Document Type: Article

References (11)

1. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol 1995; 13: 1800-1816.
2. Bekassy AN, Hermans J, Gorin NC, Gratwohl A for the Acute and Chronic Leukemia Working Parties of the European group for Blood and Marrow Transplantation. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Bone Marrow Transplant 1996; 17: 801-808.
3. Storb R, Deeg J, Pepe M et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood 1989; 73: 1729-1734.
4. Sullivan KM, Weiden PL, Storb R et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720-1728.
5. Barrett AJ, Locatelli F, Treleaven JG et al. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favorable effect of chronic GVHD on continued remission. Br J Haematol 1991; 79: 567-574.
6. Webb M, Meyer B, Jackson JM, Davies JM. Localized relapse of chronic myeloid leukaemia post allogeneic bone marrow transplantation. Br J Haematol 1993; 84: 178-181.
7. Millot F, Facon T, Kerckaert JP et al. Unusual recurrence of chronic myelogenous leukemia following bone marrow transplantation. Bone Marrow Transplant 1991; 7: 393-395.
8. Fores R, Diez-Martin JL, Cabrera JR et al. Donor leukocyte infusions for treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17: 439-441.
9. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
10. + subpopulations. Bone Marrow Transplant 1996; 17 (Suppl. 2): 22-27.
11. Fielding AK, Goldstone AH, Sullivan AM et al. Peripheral blood stem cell support does not accelerate haemopoietic recovery from miniBEAM chemotherapy. Bone Marrow Transplant 1996; 18: 507-511.